BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21351491)

  • 1. [Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis].
    Chen L; Shang J; Wang ZF; Zhang YH; Tian JD
    Yao Xue Xue Bao; 2010 Dec; 45(12):1516-22. PubMed ID: 21351491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeting of nitric oxide-donor and related drugs].
    Zhang YH; Tian JD; Peng SX
    Yao Xue Xue Bao; 2006 Jun; 41(6):481-6. PubMed ID: 16927819
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis.
    Chen L; Zhang Y; Kong X; Peng S; Tian J
    Bioorg Med Chem Lett; 2007 Jun; 17(11):2979-82. PubMed ID: 17446070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-hepatocellular carcinoma activity of novel O
    Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
    Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and anti-tumor activity of oleanolic acid derivatives].
    Meng YQ; Nie HH; Wang XC; Li D; Ge CX; Zhao N; Chen H; Cao B
    Yao Xue Xue Bao; 2011 Oct; 46(10):1215-20. PubMed ID: 22242453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
    Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
    J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of oleanolic acid derivatives as antitumor agents.
    Chen L; Wu JB; Lei F; Qian S; Hai L; Wu Y
    J Asian Nat Prod Res; 2012; 14(4):355-63. PubMed ID: 22375874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.
    Li JF; Zhao Y; Cai MM; Li XF; Li JX
    Eur J Med Chem; 2009 Jul; 44(7):2796-806. PubMed ID: 19171409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel ring-A fused hybrids of oleanolic acid with capabilities to arrest cell cycle and induce apoptosis in breast cancer cells.
    Mallavadhani UV; Vanga NR; Jeengar MK; Naidu VG
    Eur J Med Chem; 2014 Mar; 74():398-404. PubMed ID: 24487188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
    Chen L; Zhang Y; Kong X; Lan E; Huang Z; Peng S; Kaufman DL; Tian J
    J Med Chem; 2008 Aug; 51(15):4834-8. PubMed ID: 18598019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity.
    Ouazzani-Chahdi A; Elimadi A; Chabli A; Spénard J; Colin P; Haddad PS
    Can J Physiol Pharmacol; 2007 Feb; 85(2):233-42. PubMed ID: 17487265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid.
    Huang Z; Zhang Y; Zhao L; Jing Y; Lai Y; Zhang L; Guo Q; Yuan S; Zhang J; Chen L; Peng S; Tian J
    Org Biomol Chem; 2010 Feb; 8(3):632-9. PubMed ID: 20090981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and antitumor activity of oleanolic acid derivatives.
    Meng YQ; Kuai ZY; Zhan SW; Li CL; Chen HR
    J Asian Nat Prod Res; 2019 Jul; 21(7):633-651. PubMed ID: 29733221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
    Chattopadhyay M; Kodela R; Olson KR; Kashfi K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
    Fang L; Wang M; Gou S; Liu X; Zhang H; Cao F
    J Med Chem; 2014 Feb; 57(3):1116-20. PubMed ID: 24422538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and antithrombotic activity of acetylsalicyl ferulic acid-coupling furoxans and nitrates].
    Zhou Z; Jiang LY; Zhang YH; Ji H; Sun Y; Peng SX
    Yao Xue Xue Bao; 2006 Nov; 41(11):1050-6. PubMed ID: 17262946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Oleanolic Acid Analogues and Their Cytotoxic Effects on 3T3 Cell Line.
    Tuncay S; Senol H; Guler EM; Ocal N; Secen H; Kocyigit A; Topcu G
    Med Chem; 2018; 14(6):617-625. PubMed ID: 29473521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel pyrazolo[4,3-b]oleanane derivatives as inhibitors of glycogen phosphorylase.
    Chen J; Gong Y; Liu J; Hua W; Zhang L; Sun H
    Chem Biodivers; 2008 Jul; 5(7):1304-12. PubMed ID: 18649317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents.
    Zhang L; Jia X; Dong J; Chen D; Liu J; Zhang L; Wen X
    Chem Biol Drug Des; 2014 Mar; 83(3):297-305. PubMed ID: 24119242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.